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Abstract 
The morphological dynamics of astrocytes are altered in the hippocampus during memory induction. Astrocyte–
neuron interactions on synapses are called tripartite synapses. These control the synaptic function in the central 
nervous system. Astrocytes are activated in a reactive state by STAT3 phosphorylation in 5XFAD mice, an Alzheimer’s 
disease (AD) animal model. However, changes in astrocyte–neuron interactions in reactive or resting‑state astrocytes 
during memory induction remain to be defined. Here, we investigated the time‑dependent changes in astrocyte 
morphology and the number of astrocyte–neuron interactions in the hippocampus over the course of long‑term 
memory formation in 5XFAD mice. Hippocampal‑dependent long‑term memory was induced using a contextual fear 
conditioning test in 5XFAD mice. The number of astrocytic processes increased in both wild‑type and 5XFAD mice 
during memory formation. To assess astrocyte–neuron interactions in the hippocampal dentate gyrus, we counted 
the colocalization of glial fibrillary acidic protein and postsynaptic density protein 95 via immunofluorescence. Both 
groups revealed an increase in astrocyte–neuron interactions after memory induction. At 24 h after memory forma‑
tion, the number of tripartite synapses returned to baseline levels in both groups. However, the total number of 
astrocyte–neuron interactions was significantly decreased in 5XFAD mice. Administration of Stattic, a STAT3 phospho‑
rylation inhibitor, rescued the number of astrocyte–neuron interactions in 5XFAD mice. In conclusion, we suggest that 
a decreased number of astrocyte–neuron interactions may underlie memory impairment in the early stages of AD.
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Introduction
The bidirectional communication between neurons and 
astrocytes on synapses is called a tripartite synapse [1]. 
Astrocytes uptake neurotransmitters to eliminate exci-
totoxicity at the synapse. Astrocytes also release gli-
otransmitters, such as glutamate, D-serine, GABA, and 
ATP, at the synapse. These gliotransmitters bind to neu-
ronal receptors such as N-methyl-D-aspartate receptors 
(NMDARs) to modulate neuronal firing [2].
Alzheimer’s disease (AD) is characterized by amyloid 
plaques and neurofibrillary tangles in the brain [3]. AD is 
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also associated with neuronal loss and gliosis, including 
those of reactive astrocytes [4], which are found in neu-
rodegenerative diseases such as AD [5]. Reactive astro-
cytes have specific morphological characteristics, such as 
increased cell volume, dendritic thickness, and number 
of processes [6].
Our previous study had reported that astrocytes are 
activated in the reactive state via the JAK/STAT3 path-
way in 6-month-old 5XFAD mice [7]. Astrocytes showed 
dynamic changes in the number of processes during 
memory induction with contextual fear conditioning [8]. 
The administration of a STAT3 phosphorylation inhibi-
tor, Stattic, restored the cognitive function and astrocyte 
condition [7]. However, the mechanisms by which reac-
tive astrocytes affect astrocyte–neuron interactions dur-
ing memory formation remain to be elucidated.
In this study, we assessed time-dependent morpho-
logical changes in astrocytes during hippocampal long-
term memory formation in 6-month-old 5XFAD mice. In 
addition, we analyzed changes in astrocyte–neuron inter-
actions in the hippocampal dentate gyrus (DG) during 
memory formation and after the administration of Stattic 
in 6-month-old 5XFAD mice.
Results
In previous studies, we classified the type of astrocytes by 
morphological characteristic. Type II astrocytes appear 
a bipolar morphology and Type III astrocytes appear a 
radial morphology [8]. In this study, we focus on a mor-
phological dynamics and astrocyte-neuron interaction 
during memory formation with the Type III astrocytes at 
DG in hippocampus.
To assess the morphological dynamics of Type III 
astrocytes with memory impairment, we performed 
Sholl analysis in 6-month-old 5XFAD mice after memory 
induction using contextual fear conditioning test (CFC). 
The number of astrocytic processes increased after 1  h 
and 24 h of memory induction in WT mice (Fig. 1a–c). 
These morphological astrocyte dynamics increased after 
1  h only in 5XFAD mice, although the total number of 
processes was higher in 5XFAD mice (Fig. 1d).
5XFAD mice had a significantly decreased number of 
astrocyte–neuron interactions compared to WT mice 
(Fig.  1e–g), although the total number of astrocytes 
was increased compared to WT mice (Fig.  1d). During 
memory formation, the colocalization of PSD-95 and 
GFAP was significantly increased after 1 h and returned 
to the baseline level in 24 h in WT mice. Interestingly, in 
5XFAD mice, the interaction between PSD-95 and GFAP 
was also increased at 1  h and returned to the baseline 
level at 24 h (Fig. 1g).
The colocalization of PSD-95 and GFAP was signifi-
cantly decreased in the 5XFAD mice injected with vehi-
cle (5XFAD-V) compared to the WT mice injected with 
vehicle (WT-V) (Fig. 1h, i). In addition, Stattic treatment 
increased the number of PSD-95 and GFAP colocaliza-
tion in 5XFAD mice compared to that in 5XFAD-V mice 
(Fig. 1j). However, the protein expression level of GFAP 
was significantly decreased in 5XFAD mice injected with 
Stattic (5XFAD-S) than 5XFAD-V group whereas the 
expression of PSD-95 was not altered (Additional file 2: 
Fig. S1).
Discussion
The novel functions of astrocytes in memory formation 
have been extensively studied in recent decades. The 
binding of neurotransmitters to the receptors in astro-
cytes does not generate an action potential but rather 
increases the intracellular calcium concentrations, caus-
ing gliotransmitter release in a calcium-dependent man-
ner [9]. The released gliotransmitters can bind to pre- or 
postsynaptic receptors to regulate neuronal excitabil-
ity and synaptic transmission. Glutamate released from 
astrocytes binds to presynaptic NMDAR to promote 
neurotransmitter release, while ATP released from astro-
cytes suppresses synaptic transmission [10].
Fig. 1 Astrocytes’ morphological dynamics and astrocyte–neuron interaction changes during memory formation in the hippocampal DG. a 
GFAP immunofluorescence in WT and 5XFAD mice after CFC; Z‑projection depth is 0–30 μm (scale bar = 50 μm). b Gradation from red to blue 
in the 3D‑reconstructed image; 2 × digital zoom from the 400 × original image, concentric circles are spaced at 10 μm (scale bar = 50 μm). c 
Quantification of the number of intersections between processes and each circle in the hippocampal DG; WT—Cont (N = 6), 1‑h (N = 6), and 24‑h 
(N = 6) groups. d Quantification of the number of intersections between processes and each circle in the hippocampal DG; 5XFAD—Cont (N = 9), 
1‑h (N = 10), and 24‑h (N = 10) groups. e Immunofluorescence for PSD‑95 and GFAP in hippocampal DG brain slices of WT and 5XFAD mice; Cont, 
1‑h, and 24‑h groups (scale bar = 20 μm). f Reconstructed images showing a cross‑section along the X–Z axis from a confocal Z‑stack image from a 
WT and 5XFAD mouse; Cont, 1‑h, and 24‑h groups (scale bar = 20 μm). g Quantification of the colocalization of PSD‑95 and GFAP in reconstructed 
cross‑section images in the hippocampal DG; WT — Cont (N = 3), 1‑h (N = 3), and 24‑h (N = 3), 5XFAD—Cont (N = 3), 1‑h (N = 3), and 24‑h (N = 3) 
groups. h Immunofluorescence for PSD‑95 and GFAP in the hippocampal DG of WT and 5XFAD mice that were treated with vehicle or Stattic (scale 
bar = 10 μm). i Reconstructed images showing a cross‑section along the X–Z axis from a confocal Z‑stack image from WT and 5XFAD mice that 
were treated with vehicle or Stattic (scale bar = 10 μm). j Quantification of the colocalization of PSD‑95 and GFAP in the reconstructed cross‑section 
images the hippocampal DG; WT‑V (N = 4), WT‑S (N = 4), 5XFAD‑V (N = 4), 5XFAD‑S (N = 4) groups. *p < 0.05, **p < 0.01, ***p < 0.001, one‑way ANOVA 
with Fisher’s LSD post hoc analysis. Data are presented as mean ± SEM
(See figure on next page.)
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Fig. 1 (See legend on previous page.)
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Recently, reactive astrocytes were significantly 
increased in a hippocampal DG region in an Alzheimer’s 
disease model [11]. Reactive astrocytes display dynamic 
morphological changes, such as an increase in the num-
ber of processes [12]. In our previous study, we reported 
that the number of astrocyte processes increased in the 
DG during hippocampus-dependent long-term memory 
formation via CFC [8].
In this study, we assessed the morphological dynam-
ics of astrocytes in the hippocampal DG of 6-month-old 
5XFAD mice. Additionally, we examined the changes in 
astrocyte–neuron interaction in tripartite synapses dur-
ing memory formation in 5XFAD mice and found that 
decreased colocalization between astrocytes and neurons 
was recovered through the inhibition of STAT3 phospho-
rylation in 5XFAD mice.
Recent studies of tripartite synapses in the central 
nervous system have focused on membrane channels or 
transporter proteins in astrocytes. The neurotransmit-
ter–gliotransmitter negative feedback system has been 
found to be altered at the tripartite synapse because of 
cognitive impairment in a schizophrenia mouse model 
[13]. Additionally, the glutamate-glutamine shuttling sys-
tem via glutamate uptake transporters was deregulated 
at the tripartite synapse in AD-related cognitive impair-
ment [14]. In our study, we found a similar pattern of 
changes in the astrocyte–neuron interaction in the hip-
pocampal DG during memory formation between WT 
and 5XFAD mice. We also revealed a decreased colocali-
zation between astrocytes and neurons in 5XFAD mice, 
which might be the reason for memory impairment in the 
CFC test. These results suggest that memory induction 
stimulates an increase in astrocyte–neuron interaction 
during memory formation and that a sufficient number 
of astrocyte–neuron interactions would be required for 
long-term memory formation in the hippocampal DG.
In conclusion, the decreased number of astrocyte–neu-
ron interactions during the reactive state of astrocytes 
may partially underlie cognitive impairment in early-
stage AD. Furthermore, a drug that specifically inhibits 
STAT3 phosphorylation in astrocytes may represent a 
novel therapeutic strategy for early-stage AD.
In future studies, we will focus on the interaction of 
molecular and morphological changes between neurons, 
astrocytes, and microglia in the hippocampus during 
memory processes such as long-term memory formation, 
consolidation, and retrieval.
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